1. Introduction
===============

Gorgonian *Echinogorgia pseudossapo* belongs to the genus *Echinogorgia* that is known to produce sesquiterpenes and sterols \[[@b1-marinedrugs-09-02479],[@b2-marinedrugs-09-02479]\]. The zoanthoxanthins are unusual non-benzenoid aromatic zoochromic alkaloids, which have been isolated exclusively from colonial anthozoans in both major families (Epizoanthidae and Zoanthidae) of the order Zoanthidea, and appeared as three types of skeletons including 3*H*-zoanthoxanthin, 4*H*-pseudozoanthoxanthin, and 3*H*-pseudozoanthoxanthin \[[@b3-marinedrugs-09-02479]--[@b6-marinedrugs-09-02479]\]. Some of them showed histamine-like action on the guinea-pigileum and papaverine-like bioactivities \[[@b5-marinedrugs-09-02479]\]. During the course of our series investigations on the chemical constituents of the South China Sea gorgonian corals, five zoanthoxanthin alkaloids (**1**--**5**) and four sesquiterpenes (**6**--**10**) were obtained from the EtOH/CH~2~Cl~2~ extract of the South China Sea gorgonian *E. pseudossapo.* Among these compounds, pseudozoanthoxanthins III--IV (**1**--**2**) \[[@b7-marinedrugs-09-02479]\], 6β-methoxy-14-oxo-oplopa-8α-ol-6,12-olide (**6**) and 3β-methoxy-guaia-2β-ol-10(14)-ene (**7**) were new, and the known compounds were identified as zoanthoxanthin 1 (**3**) \[[@b4-marinedrugs-09-02479]\], paragracine (**4**) \[[@b4-marinedrugs-09-02479]\], zoanthoxanthin (**5**) \[[@b4-marinedrugs-09-02479]\], dehydrolindestrenolide (**8**) \[[@b8-marinedrugs-09-02479]\], and subergorgic acid (**9**) \[[@b9-marinedrugs-09-02479]\] ([Figure 1](#f1-marinedrugs-09-02479){ref-type="fig"}). The antiviral activity of **1**--**4** against herpes simplex virus type 1 (HSV-1) and antilarval activity of **7** towards *Balanus amphitrite* larvae were evaluated. In this paper, we report the isolation, structure elucidation, and bioactivities of these new compounds.

2. Results and Discussion
=========================

Compound **1** had a molecular formula of C~19~H~26~N~6~O~2~ deduced from its ESIMS and NMR data. The ^1^H and ^13^C NMR spectra of **1** were similar to those of pseudozoanthoxanthin A \[[@b3-marinedrugs-09-02479]\], pseudozoanthoxanthins I and II \[[@b6-marinedrugs-09-02479],[@b10-marinedrugs-09-02479]\], zoanthoxanthin 1 (**3**) \[[@b4-marinedrugs-09-02479]\], paragracine (**4**) \[[@b4-marinedrugs-09-02479]\] and zoanthoxanthin (**5**) \[[@b4-marinedrugs-09-02479]\] ([Table 1](#t1-marinedrugs-09-02479){ref-type="table"}), except for the addition of five methylene units and one carboxyl group (δ~C~ 176.4), which suggested that **1** has the same 3*H*-pseudozoanthoxanthin core as **4**, the difference between them existing in the side chain. The HMBC spectrum of **1** ([Figure 2](#f2-marinedrugs-09-02479){ref-type="fig"}) showed correlations of H-1′ (δ~H~ 3.20, t, *J =* 6.5 Hz) with C-2′ (δ~C~ 29.7)/C-3′ (δ~C~ 26.9), H-2′ (δ~H~ 1.54, m) with C-1′ (δ~C~ 39.9)/C-3′/C-4′ (δ~C~ 26.3), H-3′ (δ~H~ 1.35, m) with C-1′ (δ~C~ 39.9)/C-2′/C-4′/C-5′ (δ~C~ 36.7), H-4′ (δ~H~ 1.65, m) with C-3′/C-5′/C-6′ (δ~C~ 176.4), H-5′ (δ~H~ 2.21, t, *J =* 7.5 Hz ) with C-3′/C-4′/C-6′ (δ~C~ 176.4), which suggested the presence of an --N--CH~2~--CH~2~--CH~2~--CH~2~--CH~2~--COOH unit. The suggestion was supported by the ^1^H--^1^H COSY spectrum ([Figure 2](#f2-marinedrugs-09-02479){ref-type="fig"}) showing correlations of H-2′ with H-1′/H-3′, and H-4′ with H-3′/H-5′, and the ESIMS (positive) spectrum showing a main fragment ion peak at *m/z* 257 {100%, \[M + 2H--(CH~2~--CH~2~--CH~2~--CH~2~--CH~2~--COOH)\]^+^}. The weak HMBC correlations of H-1′ with C-2 (δ~C~ 160.8, s)/C-3a (δ~C~ 132.3, s) and comparison of the ^13^C NMR data of C-3a in **1** and **4** ([Table 1](#t1-marinedrugs-09-02479){ref-type="table"}) suggested that the --CH~2~--CH~2~--CH~2~--CH~2~--CH~2~--COOH unit should be attached on the nitrogen atom N(3) instead of the another nitrogen atom attached at C(2). So, the structure of **1** was determined as shown and the compound was named pseudozoanthoxanthin III.

Compound **2** had a molecular formula of C~20~H~26~N~6~O~2~ deduced from its (−) ESIMS spectrum (*m/z* 381 \[M − H\]^−^) and NMR spectra. Comparison of ^1^H and ^13^C NMR spectral data ([Table 1](#t1-marinedrugs-09-02479){ref-type="table"}) revealed close similarities between **2** and **1**. The difference between them was the absence of one methylene group and the appearance of a 1,2-disubstituted double bond \[δ~H~ 5.59 (1H, dd, *J* = 6.5, 16.0 Hz), 5.50 (1H, m), δ~C~ 130.8, 131.8\]. Extensive 2D NMR analyses, including HSQC, HMBC and ^1^H--^1^H COSY spectra proved that **1** and **2** had the same skeleton. Moreover, the HMBC spectrum showed correlations of H-1′ (δ~H~ 4.14) with C-2′ (δ~C~ 130.8)/C-3′ (δ~C~ 131.8), H-2′ (δ~H~ 5.59) with C-1′ (δ~C~ 58.6)/C-3′/C-4′ (δ~C~ 27.7), H-3′ (δ~H~ 5.50) with C-1′ (δ~C~ 58.6)/C-2′/C-4′/C-5′ (δ~C~ 25.9), H-4′ (δ~H~ 2.14) with C-3′/C-5′/C-6′ (δ~C~ 34.3), H-5′ (δ~H~ 1.69) with C-2′/C-3′/C-4′/C-6′, and H-6′ (δ~H~ 2.31) with C-4′/C-5′/C-7′ (δ~C~ 177.6), which suggested the presence of an --N--CH~2~--CH=CH-- CH~2~--CH~2~--CH~2~--COOH unit.

This suggestion was supported by the ^1^H--^1^H COSY spectrum ([Figure 2](#f2-marinedrugs-09-02479){ref-type="fig"}) showing correlations of H-2′ with H-1′/H-3′, H-4′ with H-3′/H-5′, and H-5′ with H-6′, and the (−) ESIMS spectrum showing one main fragment ion peak at *m/z* 255. In the ^1^H NMR spectrum of **2**, the coupling constant of H-2′/H-3′ (*J* = 16.0 Hz) indicated that geometric configuration of double bond H-2′/H-3′ was *E*. The weak HMBC correlations of H-1′ with C-2 (δ~C~ 160.8, s)/C-3a (δ~C~ 131.9, s) and comparison of the ^13^C NMR data of C(3a) in **2** and **4** ([Table 1](#t1-marinedrugs-09-02479){ref-type="table"}) suggested that the --CH~2~--CH=CH--CH~2~--CH~2~--CH~2~--COOH unit should be attached to the nitrogen N(3). Thus, the structure of **2** was determined as shown and named pseudozoanthoxanthin IV.

Compound **6** had the molecular formula of C~16~H~22~O~5~ as deduced from EIMS and NMR spectra. Its ^1^H NMR spectrum displayed four methyls at δ~H~ 1.80 (3H, s), 1.36 (3H, s), 2.26 (3H, s), 3.14 (3H, s). The ^13^C and DEPT-135 NMR spectra showed 17 carbons consisting of four methyls (δ~C~ 8.7, 21.9, 28.7, 50.0), three methylenes (δ~C~ 23.4, 27.0, 51.2), three methines (δ~C~ 42.1, 52.1, 56.7), two oxygenated quaternary carbons (δ~C~ 71.5, 106.9), one double bond (δ~C~ 121.4, 157.5), one lactone group (δ~C~ 171.9), and one keto group (δ~C~ 208.2). The ^1^H and ^13^C NMR spectral data of **6** showed similarity to those of 7β-hydroxyoplop-11-enone \[[@b11-marinedrugs-09-02479]\] and 7β-senecioyloxyoplopa-3(14)*Z*,8(10)-dien-2-one \[[@b12-marinedrugs-09-02479]\], which suggested that **6** was an oplopane-type sesquiterpene. The suggestion was confirmed by the HMBC and ^1^H--^1^H COSY spectra. In the HMBC spectrum ([Figure 3](#f3-marinedrugs-09-02479){ref-type="fig"}), correlations of H-4 (δ~H~ 2.65, dd, *J* = 11.0, 12.5 Hz) with C-5 (δ~C~ 157.5)/C-6 (δ~C~ 106.9)/C-8 (δ~C~ 71.5)/C-11(δ~C~ 121.4, s), H-7 (δ~H~ 2.53, 1.77, each 1H, d, *J* = 13.5 Hz) with C-6/C-8/C-9 (δ~C~ 56.7), H-9 (δ~H~ 1.84, 1H, m) with C-4 (δ~C~ 42.1)/C-5/C-8, and H-13 (δ~H~ 1.80, 3H, s) with C-5/C-11/C-12 (δ~C~ 171.9, s), suggested the presence of the B,C-ring substructure and Me-13 attached on C-11 to form a methyl substituted α,β-unsaturated γ-lactone unit. In addition, HMBC correlations of H-10 (δ~H~ 1.36, 3H, s) with C-7/C-8/C-9, and H-16 (δ~H~ 3.14, 3H, s) with C-6 (δ~C~ 106.9) indicated that Me-10 and OMe-16 were connected with C-8 and C-16, respectively. Meanwhile, the ^1^H--^1^H COSY spectrum ([Figure 3](#f3-marinedrugs-09-02479){ref-type="fig"}) showed correlations of H-1 \[δ~H~ 1.94, 1.63 (each 1H, m)\] with H-9/H-2 \[δ~H~ 2.28, 1.77 (each 1H, m)\], and H-3 (δ~H~ 3.31, ddd, *J* = 8.5, 11.0, 16.8 Hz) with H-2/H-4, suggesting the presence of A-ring unit. The suggestion was supported by HMBC correlations of H-1 with C-4/C-8/C-9, H-2 with C-1 (δ~C~ 23.4)/C-3 (δ~C~ 52.1)/C-4/C-9, and H-3 with C-2 (δ~C~ 27.0)/C-4. Furthermore, HMBC correlations of H-15 (δ~H~ 2.26, 3H, s) with C-3/C-14 (δ~C~ 208.2), and H-3 with C-14 indicated that an acetyl group was attached on C(3).

The relative stereochemistry of **6** was deduced from the NOESY spectrum ([Figure 3](#f3-marinedrugs-09-02479){ref-type="fig"}) and comparison with that of 7β-hydroxyoplop-11-enone \[[@b11-marinedrugs-09-02479]\]. NOE correlations of H-3 with H-9 indicated that H-3 and H-9 were in the same α-oriented direction, and NOE correlations of H-4 with Me-10/Me-16 suggested that H-4, Me-10, and Me-16 were on the same β-oriented side. So, the structure of **6** was elucidated as shown and named 8-hydroxy-6β-methoxy-14-oxooplop-6,12-olide. Oplopanes are frequently found in terricolous plant. However this is the first report of an oplopane-type sesquiterpene isolated from a marine animal.

Compound **7** had the molecular formula of C~16~H~28~O~2~ deduced from NMR spectra and ESIMS. The ^1^H NMR spectrum of **7** displayed signals for four methyls at δ~H~ 0.78 (3H, d, *J* = 6.9 Hz), 0.95 (3H, d, *J* = 6.9 Hz), 1.15 (3H, d, *J* = 6.5 Hz), 3.37 (3H, s) and two oxymethines at δ~H~ 3.67 (1H, dd, *J* = 7.0, 11.0 Hz), 4.15 (1H, dd, *J* = 7.0, 10.8 Hz). The ^13^C NMR spectrum showed 16 carbons including four methyls (δ~C~ 15.8, 22.0, 30.3, 57.1), three methylenes (δ~C~ 24.8, 25.9, 31.5), five high-filed sp^3^ methines (δ~C~ 29.1, 43.7, 44.5, 45.3, 53.3), two oxymethines (δ~C~ 78.3, 90.6), and one double bond \[δ~C~ 109.2 (t), 147.8 (s)\]. The ^13^C and ^1^H NMR data of **7** were similar to those of guaia-1(10),11-diene and guaia-9,11-diene \[[@b13-marinedrugs-09-02479]\], which suggested that **7** was a guaiane-type sesquiterpene.

The suggestion was supported by ^1^H--^1^H COSY and HMBC spectra ([Figure 3](#f3-marinedrugs-09-02479){ref-type="fig"}). The presence of five membered ring substructure was concluded from the ^1^H--^1^H COSY spectrum showing correlations of H-2 (δ~H~ 4.15, dd, *J* = 7.0, 10.8 Hz) with H-1 (δ~H~ 2.97, t, *J* = 7.0 Hz)/H-3 (δ~H~ 3.67, 1H, dd, *J* = 7.0, 11.0 Hz), H-4 (δ~H~ 1.73, m) with H-3/H-5 (δ~H~ 2.14, m), and H-1 with H-5. The presence of seven membered ring substructure was inferred from the ^1^H--^1^H COSY spectrum showing correlations of H-6 (δ~H~ 1.97, 1.53, each 1H, m) with H-5/H-7 (δ~H~ 1.28, m), H-8 (δ~H~ 1.67, 2H, m) with H-7/H-9 (δ~H~ 2.04, 2.24, each 1H, m), and HMBC spectrum showing correlations C-10 (δ~C~ 147.8) with H-1/H-5/H-9. Furthermore, in the HMBC spectrum, correlations of H-14 \[δ~H~ 4.64, 4.62 (each 1H, s)\] with C-1 (δ~C~ 53.3)/C-9 (δ~C~ 31.5)/C-10 suggested one double bond between C-10 and C-14. HMBC correlations of H-12 (δ~H~ 0.78, 3H, d, *J* = 6.9 Hz) and H-13 (δ~H~ 0.95, 3H, d, *J* = 6.9 Hz) with C-7 (δ~C~ 43.7)/C-11 (δ~C~ 29.1), and H-11 (δ~H~ 1.73, 1H, m) with C-7/C-12 (δ~C~ 15.8)/C-13 (δ~C~ 22.0) indicated that an isopropyl unit attached on C-7 of the seven membered ring substructure. Meanwhile, HMBC correlations of H-16 (δ~H~ 3.37, 3H, s) with C-3 (δ~C~ 90.6), and H-15 (δ~H~ 1.15, 3H, d, *J* = 6.5 Hz) with C-4 (δ~C~ 44.5), indicated that one methoxy group and one methyl were connected with C-3 and C-4, respectively.

The relative configuration of **7** was determined by a NOESY experiment ([Figure 3](#f3-marinedrugs-09-02479){ref-type="fig"}) and comparison with that of guaia-1(10),11-diene and guaia-9,11-diene \[[@b13-marinedrugs-09-02479]\]. Considering the bulky isopropyl group to keep a *pseudo* equatorial position and being β-oriented, H-7 had to be α-oriented. NOE correlations of H-1 with H-2/H-3/H-5, H-2 with H-5, H-3 with H-5/H-7/Me-15, and H-7 with H-5/Me-15 suggested that H-1, H-2, H-3, H-5, and Me-15 were oriented in the same direction as H-7, and should be α-orientation. Based on the above data, the structure of **7** was determined as shown and named 3β-methoxyguaian-10(14)-en-2β-ol.

*In vitro* antiviral activity of **1**--**4** against HSV-1 was evaluated using plaque reduction assay. First, the completely non-toxic concentration (CC~0~) of **1**--**4** and positive control ACV on Vero cells were tested to be 270.3, 523.6, 185.2, 195.3, \>7500 μM by MTT assays, respectively, then for further antivirus studies, the concentrations of tested compounds were kept below their CC~0~ values. The antiviral assays displayed that **1**--**4** exhibited anti-HSV-1 activity with EC~50~ (50% effective concentration required to inhibit virus-induced cytopathicity 50%) values of 108.1, 471.2, 70.4, 117.2, 6.08 μM, respectively. The results suggested that the side chain at the nitrogen N(3) in **1**--**4** could affect their antiviral activity. Although **1** and **3** showed mild anti-HSV-1 activity, their activities were far lower than that of the positive control ACV.

Compound **7** was evaluated for its antilarval activity against *B. amphitrite* and *B. neritina* larvae. The results showed that **7** had significant antilarval activity towards *B. amphitrite* larvae with EC~50~ value of 17.2 μg/mL (68.2 μM), and showed 50% inhibition towards the settlement of *B. neritina* larvae at concentration of 25 μg/mL. The EC~50~ value of **7** is lower than the standard requirement of an EC~50~ of 25 μg/mL established by the US Navy program as an efficacy level for natural antifoulants, indicating that **7** is a potential natural antifouling agent.

3. Experimental Section
=======================

3.1. General
------------

Optical rotations were measured with a Horiba SEAP-300 spectropolarimeter. UV spectra were measured with a Shimadzu double-beam 210A spectrophotometer in MeOH solution. ^1^H, ^13^C NMR and 2D NMR spectra were recorded on a Bruker AV-500 MHz NMR spectrometer with TMS as internal standard. MS spectral data were obtained on an LCQDECA XP HPLC/MSn spectrometer for ESIMS.

3.2. Animal Material
--------------------

The South China Sea gorgonian coral *E. pseudossapo* (7.8 kg, wet weight) was collected in Sanya, Hainan Province, China in October 2007 and identified by Research Assistant Xiubao Li, the South China Sea Institute of Oceanology, Academia Sinica (SCSIO). A voucher specimen (No. 2007-SCSIO-3) was deposited in SCSIO, Guangzhou, China.

3.3. Extraction and Isolation
-----------------------------

The frozen specimens of *E. pseudossapo* were exhaustively extracted with EtOH/CH~2~Cl~2~ (2:1) three times at room temperature, and the solvent was evaporated in *vacuo*. The residue was partitioned in H~2~O and extracted with EtOAc and *n*-BuOH in turn three times, respectively. The *n*-BuOH extract was concentrated in *vacuo* to afford 10.2 g of residue, and then the *n*-BuOH portion was subjected to column chromatography on silica, using CHCl~3~/MeOH (from 10:0 to 0:10) as eluent. By combining the fractions with TLC (GF254) monitoring, 8 fractions were obtained. Fraction 2 was chromatographed over Sephadex LH-20 eluting with CHCl~3~/MeOH (1:1) to obtain three sub-fractions (A--C). Sub-fraction B was purified over semi-preparative HPLC with MeOH/water (50:50) to yield **1** (10 mg) and **3** (4.0 mg). Sub-fraction C were purified over semi-preparative HPLC eluted with MeOH/H~2~O (60:40) to yield **2** (10.1 mg), **4** (13.0 mg), and **5** (2.3 mg). The EtOAc extracts were concentrated *in vacuo* to afford 33.5 g of residue. The EtOAc portion was subjected to column chromatography (CC) on silica, using petroleum ether-EtOAc (from 10:1 to 0:10) as eluent. By combining the fractions with TLC (GF254) monitoring, 16 fractions were obtained. Fraction 7 was purified by silica gel column, eluted with petroleum ether-EtOAc (2:1) to yield **8** (17.0 mg). Fraction 8 was subjected to CC on silica gel, eluted with CHCl~3~-Me~2~CO (from 100:5 to 0:10), and then purified with semi-preparative HPLC, using MeOH-water as eluent to afford **6** (10.0 mg) and **9** (6.4 mg). Fraction 10 was chromatographed over Sephadex LH-20 eluting with CHCl~3~/MeOH(1:1), then repeatedly subjected to CC on Si gel, eluted with CHCl~3~/MeOH (from 10:0 to 6:4) to yield **7** (10.3 mg).

*Pseudozoanthoxanthin III* (**1**): Yellow oil; UV (MeOH) λ~max~ 221, 257, 304, 362 nm; IR (KBr) ν~max~ 3400, 3300, 1750, 1690, 1620 cm^−1^; ^1^H NMR and ^13^C NMR spectral data, see [Table 1](#t1-marinedrugs-09-02479){ref-type="table"}; ESI-MS (+) *m/z* 371 \[M + H\]^+^; HRESIMS *m/z* 371.2159 \[M + H\]^+^ (calcd for C~19~H~27~N~6~O~2~ 371.2195).

*Pseudozoanthoxanthin IV* (**2**): Yellow oil; UV (MeOH) λ~max~ 221, 257, 304, 362 nm; IR (KBr) ν~max~ 3407, 3313, 1752, 1694, 1623 cm^−1^; ^1^H NMR and ^13^C NMR spectral data see [Table 1](#t1-marinedrugs-09-02479){ref-type="table"}; ESI-MS(−) *m/z* 381 \[M − H\] ^−^; HRESIMS *m/z* 381.2075 \[M − H\] ^−^ (calcd for C~20~H~25~N~6~O~2~, 381.2039).

*8a-hydroxy-6β-methoxy-14-oxooplop-6,12-olide* (**6**): Colorless oil; \[α\]^25^ ~D~ +0.3 (c 0.10, MeOH); UV (MeOH): 225 nm; IR (KBr) ν~max~ 3276, 1723, 1625 cm^−1^; ^1^H NMR(500 MHz, CDCl~3~) δ~H~: 1.94, 1.63 (each 1H, m, H-1), 2.28, 1.77 (each 1H, m, H-2), 3.31 (1H, ddd, *J =* 8.5, 11.0, 16.8 Hz, H-3), 2.65 (1H, *J =* 11.0, 12.5 Hz, H-4), 2.53, 1.77 (each 1H, d, *J =* 13.5 Hz, H-7), 1.84 (1H, m, H-9), 1.36 (3H, s, Me-10), 1.80 (3H, s, Me-13), 2.26 (3H, s, Me-15), 3.14 (3H, s, OMe-16); ^13^C NMR (125 MHz, CDCl~3~) δ~C~: 23.4 (C-1), 27.0 (C-2), 52.1 (C-3), 42.1 (C-4), 157.5 (C-5), 106.9 (C-6), 51.2 (C-7), 71.5 (C-8), 56.7 (C-9), 21.9 (C-10), 121.4 (C-11), 171.9 (C-12), 8.7 (C-13), 208.2 (C-14), 28.7 (C-15), 50.0 (C-16); HR-EI-MS *m/z* 294.1472 \[M\]^+^ (calcd for C~16~H~22~O~5~, 294.1467).

*3β-methoxyguaian-10(14)-en-2β-ol* (**7**): Colorless oil; \[α\]^25^ ~D~ +0.8 (c 0.10, MeOH); IR (KBr) ν~max~ 3446, 1648, 1456 cm^−1^; ^1^H NMR(500 MHz, CDCl~3~) δ~H~: 2.97 (1H, t, *J =* 7.0 Hz, H-1), 4.15 (1H, dd, *J =* 7.0, 10.8 Hz, H-2), 3.67 (1H, dd, *J =* 7.0, 11.0 Hz, H-3), 1.73 (1H, m, H-4), 2.14 (1H, m, H-5), 1.97, 1.53 (each 1H, m, H-6), 1.28 (1H, m, H-7), 1.67 (2H, m, H-8), 2.04, 2.24 (2H, m, H-9), 1.73 (1H, m, H-11), 0.78 (3H, d, *J =* 6.9 Hz, Me-12), 0.95 (3H, d, *J =* 6.9 Hz, Me-13), 4.64, 4.62 (each 1H, s, H-14), 1.15 (3H, d, *J =* 6.5 Hz, Me-15), 3.37 (3H, s, OMe-16); ^13^C NMR (125 MHz, CDCl~3~) δ~C~: 53.3 (C-1), 78.3 (C-2), 90.6 (C-3), 44.5 (C-4), 45.3 (C-5), 25.9 (C-6), 43.7 (C-7), 24.8 (C-8), 31.5 (C-9), 147.8 (C-10), 29.1 (C-11), 15.8 (C-12), 22.0 (C-13), 109.2 (C-14), 30.3 (C-15), 57.1 (C-16); HR-EI-MS *m/z* 252.2082 \[M\]^+^ (calcd for C~16~H~28~O~2~, 252.2089).

3.4. Viruses and Cells
----------------------

HSV-1 (15577) strain and Vero cells were obtained from American Type Culture Collection. Cytotoxicity assay and cytopathic effect reduction assay were undertaken with the reported methods \[[@b14-marinedrugs-09-02479]\]. ACV was used as the positive control.

3.5. Larval Settlement Bioassays
--------------------------------

Antilarval activity of the compounds was evaluated in settlement inhibition assays with laboratory-reared *Balanus amphitrite* and *Bugula neritina* larvae. The procedures were the same as previously reported \[[@b15-marinedrugs-09-02479]\].

4. Conclusion
=============

In conclusion, our investigation on the chemical constituents of gorgonian *E. pseudossapo* led to the obtainment of five zoanthoxanthin alkaloids (**1**--**5**) and four sesquiterpenes (**6**--**9**). Among these compounds, **1**, **2**, **6** and **7** were new, **1** and **3** showed moderate anti-HSV-1 and anti-RSV activity, and **7** showed significant antilarval activity towards *B. amphitrite* larvae. The results elucidate the basis of medicinal substances of *E. pseudossapo*, and suggest that **7** is a potential natural antifouling agent.
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###### 

^1^H NMR (500 MHz) and ^13^C NMR (125 MHz) data of 1, 2, 4 (in CD~3~OD, δ in ppm).

  Position   1                                   2                                    4
  ---------- --------------------- ------------- ---------------------- ------------- -------
  2                                160.8, C                             160.8, C      161.0
  3a                               132.3, C                             131.9, C      140.4
  3b                               152.5, C                             152.7, C      153.1
  5                                161.3, C                             161.5, C      162.1
  6a                               142.3, C                             143.2, C      143.5
  7          7.84 (d, 10.3)        121.9, CH     7.87 (d, 9.5)          119.6, CH     119.5
  8          7.79 (d, 10.3)        133.1, CH     7.80 (d, 9.5)          133.5, CH     133.1
  9                                147.7, C                             148.4, C      148.0
  9a                               135.0, C                             135.1, C      135.5
  2-NMe      3.23 (s)              29.8, CH~3~   3.38 (s)               29.7, CH~3~   29.8
  5-NMe      3.38 (s)              38.7, CH~3~   3.33 (s)               38.6, CH~3~   37.8
  Me-9       2.86 (s)              23.3, CH~3~   2.85 (s)               23.4, CH~3~   23.4
  1′         3.20 (t, 6.5)         39.9, CH~2~   4.14 (d, 6.5)          58.6, CH~2~   
  2′         1.54 (tt, 6.5, 7.0)   29.7, CH~2~   5.59 (dd, 6.5, 16.0)   130.8, CH     
  3′         1.35 (tt, 7.0, 7.4)   26.9, CH~2~   5.50 (dd, 7.4, 16.0)   131.8, CH     
  4′         1.65 (qt, 7.4, 7.5)   26.3, CH~2~   2.14 (dt, 7.4, 7.5)    27.7, CH~2~   
  5′         2.21 (t, 7.5)         36.7, CH~2~   1.69 (qt, 7.5, 7.5)    25.9, CH~2~   
  6′                               176.4, C      2.31 (t, 7.5)          34.3, CH~2~   
  7′                                                                    177.6, C      
